No Data
No Data
Masimo (MASI), Cleveland Clinic Unite to Enhance Patient Care
Barclays Maintains DaVita(DVA.US) With Hold Rating, Maintains Target Price $150
Barclays analyst Andrew Mok CFA maintains $DaVita(DVA.US)$ with a hold rating, and maintains the target price at $150.According to TipRanks data, the analyst has a success rate of 46.1% and a total av
BD's (BDX) New Research Tool to Aid Single-Cell Analysis
Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock?
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now